USA
Acceder
Cotización de Amylyx Pharmaceuticals, Inc. (AMLX) hoy en tiempo real
Análisis técnico y gráfico histórico de Amylyx Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Amylyx Pharmaceuticals, Inc.
Ficha de Amylyx Pharmaceuticals, Inc. (AMLX)
| Ticker | AMLX |
|---|---|
| ISIN | US03237H1014 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Amylyx Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Amylyx Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Amylyx Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Amylyx Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Amylyx Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Amylyx Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Amylyx Pharmaceuticals, Inc.
Invertir en Amylyx Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquar...
¿En qué sector opera Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.
Otras acciones del sector Atención sanitaria